Edition:
United Kingdom

Regulus Therapeutics Inc (RGLS.OQ)

RGLS.OQ on NASDAQ Stock Exchange Global Market

1.97USD
16 Oct 2018
Change (% chg)

$0.03 (+1.55%)
Prev Close
$1.94
Open
$1.94
Day's High
$2.05
Day's Low
$1.94
Volume
9,867
Avg. Vol
17,259
52-wk High
$17.22
52-wk Low
$1.89

Chart for

About

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs to treat a range of diseases. The Company uses its microRNA product platform to develop chemically modified, single-stranded oligonucleotides that the Company calls anti-miRs to modulate microRNAs and return... (more)

Overall

Beta: 1.65
Market Cap(Mil.): $142.19
Shares Outstanding(Mil.): 103.79
Dividend: --
Yield (%): --

Financials

  RGLS.OQ Industry Sector
P/E (TTM): -- 86.20 32.69
EPS (TTM): -1.53 -- --
ROI: -95.74 0.73 14.32
ROE: -149.70 1.82 16.04

BRIEF-Kathryn Collier Joins Regulus Board Of Directors

* KATHRYN J. COLLIER JOINS REGULUS BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

17 Apr 2018

Competitors

Earnings vs. Estimates